INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 19 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $10,000 | -67.7% | 21,300 | -61.1% | 0.00% | – |
| Q1 2018 | $31,000 | -41.5% | 54,790 | -16.0% | 0.00% | – |
| Q4 2017 | $53,000 | -33.8% | 65,250 | -19.3% | 0.00% | – |
| Q3 2017 | $80,000 | -37.5% | 80,900 | +32.4% | 0.00% | – |
| Q2 2017 | $128,000 | -58.2% | 61,100 | -50.0% | 0.00% | – |
| Q1 2017 | $306,000 | -12.1% | 122,200 | -0.2% | 0.00% | – |
| Q4 2016 | $348,000 | +167.7% | 122,400 | +97.7% | 0.00% | – |
| Q3 2016 | $130,000 | +41.3% | 61,900 | +4.2% | 0.00% | – |
| Q2 2016 | $92,000 | -15.6% | 59,400 | +12.4% | 0.00% | – |
| Q1 2016 | $109,000 | -2.7% | 52,841 | -5.0% | 0.00% | – |
| Q4 2015 | $112,000 | +2.8% | 55,641 | -6.8% | 0.00% | – |
| Q3 2015 | $109,000 | -41.7% | 59,700 | -6.3% | 0.00% | – |
| Q2 2015 | $187,000 | +10.0% | 63,741 | +4.3% | 0.00% | – |
| Q1 2015 | $170,000 | +23.2% | 61,138 | 0.0% | 0.00% | – |
| Q4 2014 | $138,000 | -52.6% | 61,138 | -36.7% | 0.00% | – |
| Q3 2014 | $291,000 | -68.9% | 96,638 | -60.7% | 0.00% | – |
| Q2 2014 | $936,000 | +50.0% | 245,670 | +73.3% | 0.00% | – |
| Q1 2014 | $624,000 | +184.9% | 141,750 | +140.7% | 0.00% | – |
| Q4 2013 | $219,000 | – | 58,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 75,895 | $159,000 | 0.02% |
| FIRST FOUNDATION ADVISORS | 100,900 | $212,000 | 0.02% |
| Argent Trust Co | 15,121 | $32,000 | 0.01% |
| Acrospire Investment Management LLC | 1,500 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 33,485 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,846 | $20,000 | 0.00% |
| Advisor Group, Inc. | 11,791 | $25,000 | 0.00% |
| Hudson Bay Capital Management LP | 10,000 | $21,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |